when is semaglutide off patent expiry in India opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent Patent expires next year: Novo

When prescribed correctly, these medications are part of a broader treatment plan rather than a standalone solution

In individuals with type 2 diabetes treated with insulin, CGM, both intermittently scanned CGM and real-time CGM, has gained traction, with evidence that CGM results in better overall glucose control as defined by HbA 1c and time in range (3.910.0 mmol/l [70180 mg/dl]), fewer hyperglycaemic and hypoglycaemic episodes and improvements in diabetes distress [336, 337]

It also causes cellular CO toxicity and bilirubin encephalopathy

Pero todava hace falta ms difusin para informar por completo tanto a los pacientes como a los proveedores sobre el programa, dice Anders Gilberg, vicepresidente snior de asuntos del Gobierno de la Asociacin de Administracin de Grupos Mdicos